Luteolin protects PC12 cells from rotenone-induced apoptosis

Neural Regeneration Research

Volumn 5, Issue 24, 2010, Pages 1870-1874

  Zhu, Lihong ^a,b   Qi, Renbin ^a,b   Wang, Huadong ^a,b   Bi, Wei ^c   Wang, Zhigang ^a,b   Zeng, Qi ^a,b   Zhao, Yanru ^a,b   Lu, Daxiang ^a,b  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

^c SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Apoptosis; Cleaved caspase 3; Luteolin; Parkinson's disease; PC12 cells; Rotenone

Indexed keywords

CASPASE 3; LUTEOLIN; ROTENONE;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL PROTECTION; CELL STRAIN; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; IN VITRO STUDY; PARKINSON DISEASE; PROTEIN EXPRESSION;

EID: 78751607621     PISSN: 16735374     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Newhouse K, Hsuan SL, Chang SH, et al. Rotenone-induced apoptosis is mediated by p38 and JNK MAP kinases in human dopaminergic SH-SY5Y cells. Toxicol Sci. 2004;79(1):137-146.
2. Pei W, Liou AK, Chen J. Two caspase-mediated apoptotic pathways induced by rotenone toxicity in cortical neuronal cells. FASEB J. 2003;17(3):520-522.
3. Yuan H, Zheng JC, Liu P, et al. Pathogenesis of Parkinson's disease: oxidative stress, environmental impact factors and inflammatory processes. Neurosci Bull. 2007;23(2):125-130.
4. Marjama-Lyons JM, Koller WC. Parkinson's disease. Update in diagnosis and symptom management. Geriatrics. 2001;56(8): 24-25, 29-30, 33-35.
5. Olanow CW, Stocchi F. COMT inhibitors in Parkinson's disease: can they prevent and/or reverse levodopa-induced motor complications? Neurology. 2004;62(1 Suppl 1):S72-S81.
6. Esselink RA, de Bie RM, de Haan RJ, et al. Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD: a randomized trial. Neurology. 2004;62(2):201-207.
7. Baluchnejadmojarad T, Roghani M, Mafakheri M. Neuroprotective effect of silymarin in 6-hydroxydopamine hemi-parkinsonian rat: involvement of estrogen receptors and oxidative stress. Neurosci Lett. 2010;480(3):206-210.
8. Gillies GE, McArthur S. Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines. Pharmacol Rev. 2010;62(2):155-198.
9. Huber JC, Schneeberger C, Tempfer CB. Genetic modelling of the estrogen metabolism as a risk factor of hormone-dependent disorders. Maturitas. 2002;42(1):1-12.
10. Sawada H, Ibi M, Kihara T, et al. Estradiol protects dopaminergic neurons in a MPP + Parkinson's disease model. Neuropharmacology. 2002;42(8):1056-1064.
11. Bureau G, Longpré F, Martinoli MG. Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation. J Neurosci Res. 2008;86(2): 403-410.
12. Ueda H, Yamazaki C, Yamazaki M. Luteolin as an anti-inflammatory and anti-allergic constituent of Perilla frutescens. Biol Pharm Bull. 2002;25(9):1197-1202.
13. Saunders-Pullman R, Gordon-Elliott J, Parides M, et al. The effect of estrogen replacement on early Parkinson's disease. Neurology. 1999;52(7):1417-1421.
14. Seelinger G, Merfort I, Schempp CM. Anti-oxidant, anti-inflammatory and anti-allergic activities of luteolin. Planta Med. 2008;74(14):1667-1677.
15. López-Lázaro M. Distribution and biological activities of the flavonoid luteolin. Mini Rev Med Chem. 2009;9(1):31-59.
16. Tsuruga M, Dang Y, Shiono Y, et al. Differential effects of vitamin E and three hydrophilic antioxidants on the actinomycin D-induced and colcemid-accelerated apoptosis in human leukemia CMK-7 cell line. Mol Cell Biochem. 2003;250(1-2):131-137.
17. Kang SS, Lee JY, Choi YK, et al. Neuroprotective effects of flavones on hydrogen peroxide-induced apoptosis in SH-SY5Y neuroblostoma cells. Bioorg Med Chem Lett. 2004;14(9): 2261-2264.
18. Pavlica S, Gebhardt R. Protective effects of flavonoids and two metabolites against oxidative stress in neuronal PC12 cells. Life Sci. 2010;86(3-4):79-86.
19. Liu R, Gao M, Qiang GF, et al. The anti-amnesic effects of luteolin against amyloid beta(25-35) peptide-induced toxicity in mice involve the protection of neurovascular unit. Neuroscience. 2009; 162(4):1232-1243.
20. Park E, Kum S, Wang C, et al. Anti-inflammatory activity of herbal medicines: inhibition of nitric oxide production and tumor necrosis factor-alpha secretion in an activated macrophage-like cell line. Am J Chin Med. 2005;33(3):415-424.
21. Kim JS, Lee HJ, Lee MH, et al. Luteolin inhibits LPS-stimulated inducible nitric oxide synthase expression in BV-2 microglial cells. Planta Med. 2006;72(1):65-68.
22. Chen HQ, Jin ZY, Wang XJ, et al. Luteolin protects dopaminergic neurons from inflammation-induced injury through inhibition of microglial activation. Neurosci Lett. 2008;448(2):175-179.
23. Jang S, Dilger RN, Johnson RW. Luteolin inhibits microglia and alters hippocampal-dependent spatial working memory in aged mice. J Nutr. 2010;140(10):1892-1898.
24. Shafer TJ, Atchison WD. Transmitter, ion channel and receptor properties of pheochromocytoma (PC12) cells: a model for neurotoxicological studies. Neurotoxicology. 1991;12(3):473-492.
25. Kozminski KD, Gutman DA, Davila V, et al. Voltammetric and pharmacological characterization of dopamine release from single exocytotic events at rat pheochromocytoma (PC12) cells. Anal Chem. 1998;70(15):3123-3130.
26. Shamoto-Nagai M, Maruyama W, Kato Y, et al. An inhibitor of mitochondrial complex I, rotenone, inactivates proteasome by oxidative modification and induces aggregation of oxidized proteins in SH-SY5Y cells. J Neurosci Res. 2003;74(4):589-597.
27. Fleming SM, Zhu C, Fernagut PO, et al. Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone. Exp Neurol. 2004;187(2):418-429.
28. Liu HQ, Zhu XZ, Weng EQ. Intracellular dopamine oxidation mediates rotenone-induced apoptosis in PC12 cells. Acta Pharmacol Sin. 2005;26(1):17-26.
29. Swarnkar S, Singh S, Mathur R, et al. A study to correlate rotenone induced biochemical changes and cerebral damage in brain areas with neuromuscular coordination in rats. Toxicology. 2010;272(1-3):17-22.
30. Moon DO, Kim KC, Jin CY, et al. Inhibitory effects of eicosapentaenoic acid on lipopolysaccharide-induced activation in BV2 microglia. Int Immunopharmacol. 2007;7(2):222-229.
31. Hu J, Wh T, Wh C, et al. Protective effects of 20-hydroxyecdysone on CoCl2-induced cell injury in PC12 cells. J Cell Biochem. 2010.
32. Singh NP, McCoy MT, Tice RR, et al. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res. 1988;175(1):184-191.
33. Suzuki K, Hino M, Kutsuna H, et al. Selective activation of p38 mitogen-activated protein kinase cascade in human neutrophils stimulated by IL-1beta. J Immunol. 2001;167(10):5940-5947.